Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Italy +3
  • Study on Zilucoplan Sodium for Children Aged 2 to 17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Italy Poland
  • Study on the Long-Term Safety of Zilucoplan in Children with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Italy Poland
  • Study on Nipocalimab for Children Aged 2-17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Poland
  • A Phase 2a Study of Empasiprubart IV Monotherapy in Adults with AChR‑Ab Seropositive Generalized Myasthenia Gravis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Belgium Germany Greece Italy The Netherlands Poland +1
  • Oral corticosteroid tapering with ravulizumab, prednisone and prednisolone in adult patients with generalized myasthenia gravis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Germany Italy
  • A Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Germany Italy Spain
  • Study of TOL2 safety and immune response in patients with generalized myasthenia gravis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Denmark Germany Sweden
  • Study on Rituximab for Patients with Generalized Myasthenia Gravis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Italy
  • Study on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Czechia Denmark France Italy The Netherlands Norway +3